Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fruchart

Showing results (401-410 of 562) with videos related to

Pageof 57
Sort By:
The Journal of Biological Chemistry|February 25, 1991
The epitopes of apolipoprotein A-I define distinct structural domains including a mobile middle regionY L Marcel, P R Provost, H Koa, et al.
Atherosclerosis|October 11, 1991
Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery diseaseJ J Genest, J M Bard, J C Fruchart, et al.
The Journal of Biological Chemistry|April 25, 2000
Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular targetG Martin, H Poirier, N Hennuyer, et al.
Circulation|February 24, 2001
PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophagesB P Neve, D Corseaux, G Chinetti, et al.
Metabolism: Clinical and Experimental|December 1, 1991
High-density lipoprotein particles in octogenariansG Luc, J M Bard, S Lussier-Cacan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 14, 1990
Lipoprotein particles in homozygous familial hypercholesterolemic patients treated with portacaval shunt and LDL apheresisD Gairin, F Monard, C Cachera, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1991
[Liaison of apolipoprotein A with adipose cells: characteristics of the receptor sites and their role in the efflux of cholesterol]R Barbaras, P Puchois, A Pradines-Figuères, et al.
Presse Medicale (Paris, France : 1983)|December 17, 1988
[Type IIa dyslipoproteinemia. Effects of simvastatin and bezafibrate on atherogenic and non-atherogenic lipoprotein particles]J M Lecerf, J M Bard, V Leclerc, et al.
Clinical Chemistry|June 1, 1987
Electroimmunoassay for determination of ApoB in human sera by using a mixture of monoclonal antibodiesI Pruvot, C Fievet, J C Fruchart, et al.
Die Pharmazie|September 12, 2003
Hawthorn extracts inhibit LDL oxidationC Quettier-Deleu, G Voiselle, J C Fruchart, et al.
Pageof 57

Showing results (401-410 of 562) with videos related to

Sort By:
Pageof 57
The Journal of Biological Chemistry|February 25, 1991
The epitopes of apolipoprotein A-I define distinct structural domains including a mobile middle regionY L Marcel, P R Provost, H Koa, et al.
Atherosclerosis|October 11, 1991
Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery diseaseJ J Genest, J M Bard, J C Fruchart, et al.
The Journal of Biological Chemistry|April 25, 2000
Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular targetG Martin, H Poirier, N Hennuyer, et al.
Circulation|February 24, 2001
PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophagesB P Neve, D Corseaux, G Chinetti, et al.
Metabolism: Clinical and Experimental|December 1, 1991
High-density lipoprotein particles in octogenariansG Luc, J M Bard, S Lussier-Cacan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 14, 1990
Lipoprotein particles in homozygous familial hypercholesterolemic patients treated with portacaval shunt and LDL apheresisD Gairin, F Monard, C Cachera, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1991
[Liaison of apolipoprotein A with adipose cells: characteristics of the receptor sites and their role in the efflux of cholesterol]R Barbaras, P Puchois, A Pradines-Figuères, et al.
Presse Medicale (Paris, France : 1983)|December 17, 1988
[Type IIa dyslipoproteinemia. Effects of simvastatin and bezafibrate on atherogenic and non-atherogenic lipoprotein particles]J M Lecerf, J M Bard, V Leclerc, et al.
Clinical Chemistry|June 1, 1987
Electroimmunoassay for determination of ApoB in human sera by using a mixture of monoclonal antibodiesI Pruvot, C Fievet, J C Fruchart, et al.
Die Pharmazie|September 12, 2003
Hawthorn extracts inhibit LDL oxidationC Quettier-Deleu, G Voiselle, J C Fruchart, et al.
Pageof 57